Back to search

Article

The Impact of GST Genetic Polymorphisms on the Response to Oxaliplatin-Based Chemotherapy and Survival Prognosis in Gastric Cancer Patients

2025-08-12

Abstract excerpt

<title>Abstract</title> <p>Purpose The majority of gastric cancer (GC) cases are diagnosed at advanced stages, with chemotherapy serving as the primary treatment modality. However, the efficacy of this approach is significantly influenced by individual genetic variations. A nuanced understanding of genetic associations can aid in predicting treatment response and survival outcomes in patients. Consequently, this...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9c6b068a-29e4-5378-a31f-d31989e407c1
DOI
10.21203/rs.3.rs-7267186/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Impact of GST Genetic Polymorphisms on the Response to Oxaliplatin-Based Chemotherapy and Survival Prognosis in Gastric Cancer PatientsDOI 10.21203/rs.3.rs-7267186/v1
The impact of GST genetic polymorphisms on the response to oxaliplatin-based chemotherapy and survival prognosis in gastric cancer patients.Semantic proximity
Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphismsSemantic proximity
XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis.Semantic proximity
GSTM1 and GSTP1 Polymorphisms Affect Outcome in Colorectal Adenocarcinoma.Semantic proximity
Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population.Semantic proximity
GSTP1, ERCC1 and ERCC2 polymorphisms, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in colorectal cancer in Chinese population.Semantic proximity
Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.Semantic proximity
Genetic polymorphism of GSTP1: prediction of clinical outcome to oxaliplatin/5-FU-based chemotherapy in advanced gastric cancer.Semantic proximity
Relationship between glutathione S-transferase M1 gene polymorphism and gastric cancer.Semantic proximity
Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer.Semantic proximity
Association between GSTM1, GSTT1, and GSTP1 polymorphisms and gastric cancer risk, and their interactions with environmental factors.Semantic proximity
Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms.Semantic proximity
Select a neighboring publication to make it the new centre.